EARLY-STAGE NON-SMALL CELL LUNG CANCER IN THE ELDERLY: PATHOLOGICAL CHARACTERISTICS AND PROGNOSTIC FACTORS AFTER SURGICAL RESECTION AT THONG NHAT HOSPITAL

Đỗ Nhân Nguyễn

Main Article Content

Abstract

Background: Non-small cell lung cancer (NSCLC) has become increasingly prevalent in Vietnam due to advances in screening and imaging techniques. However, curative surgery in elderly patients remains challenging owing to comorbidities, postoperative complications, and heterogeneity in biological age, pathological characteristics and prognostic outcomes following surgery in this population are still underreported. Subjects and Methods: A cross-sectional descriptive study was conducted on 56 elderly patients diagnosed with early-stage NSCLC who underwent surgical resection and follow-up at Thong Nhat Hospital between June 2018 and December 2024. The objective was to evaluate clinicopathological features and postoperative prognostic factors. Results and Discussion: The mean age was 72.8, with males accounting for 78.6%, and 44.6% having a history of smoking. Comorbidity was common (CCI ≥3 in 60.7%). Adenocarcinoma was the predominant histologic type (67.9%), with poor differentiation seen in 25%. Stage I disease accounted for 71.4% of cases. Factors significantly associated with postoperative complications included ASA class III or higher (p=0.04), CCI ≥3 (p=0.01), and open surgery (p=0.03). The 5-year disease-free survival (DFS) rate was 82.1%, and overall survival (OS) was 68%. With a median follow-up of 48.5 months, nodal metastasis (N2+), high CCI, and poorly differentiated tumors were independently associated with decreased 5-year survival based on Cox regression analysis. Conclusion: Surgical resection for early-stage NSCLC in elderly patients yields favorable survival outcomes when appropriate selection is applied. Adverse prognostic factors include postoperative N2 nodal positivity, poorly differentiated histology, and CCI ≥3. These findings may contribute to optimizing curative treatment strategies for elderly lung cancer patients.

Article Details

References

Gregory J Riely , Douglas E Wood , David S Ettinger, et al. Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 May;22(4):249-274
2. Okami J, et al. Surgical outcomes of VATS lobectomy in elderly NSCLC patients: a multicenter analysis. Gen Thorac Cardiovasc Surg. 2020;68(12):1442–1449.
3. Goldstraw P, Chansky K, Crowley J, et al. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2016;11(1):39–51.
4. Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol. 2015;10(9):1243–1260.
5. Nakamura H, et al. Comorbidity index and surgical outcomes in elderly patients with early-stage NSCLC. J Thorac Dis. 2020;12(6):3148–3156.
6. Lee JH, et al. Influence of comorbidities on survival after lung cancer surgery in elderly. Korean J Thorac Cardiovasc Surg. 2021;54(4):243–250.
7. Gossot D, et al. Minimally invasive surgery for lung cancer in the elderly. Eur J Cardiothorac Surg. 2021;59(1):48–54.
8. Kim HK, et al. Comparative outcomes of VATS vs. open lobectomy in elderly NSCLC patients. Ann Thorac Surg. 2022;113(3):752–760.
9. Zhang J, et al. Lymph node status and survival in resected stage I–II NSCLC: a SEER analysis. Lung Cancer. 2021;160:1–9.
10. Tsutani Y, et al. Prognostic impact of nodal metastasis in elderly patients with early-stage NSCLC. J Thorac Oncol. 2020;15(9):1462–1470.